Edinburgh Research & Innovation, the commercialisation arm of Edinburgh University, entered a licence agreement with healthcare company Merck on Monday for a technology that enables the use of fluorescent peptides to analyse the progression of diseases in the early stages. The technology was developed by Marc Vendrell’s team at the School of Clinical Sciences, along with Rodolfo Lavilla of Barcelona University and Nick Read of Manchester University. Financial terms were not disclosed.
Myleus Biotechnology, a spinout of Federal University of Minas Gerais that provides DNA testing services for food companies and researchers, has received an undisclosed amount from VC fund Primatec, according to Lavca. The cash will support an expansion of the spinout’s commercial activities. The company previously obtained seed capital from Fundepar in 2014.
Japan-based prepaid solar power utility Digital Grid has raised $2.9m in series B funding from government agency Japan International Cooperation Agency, The Bridge reported yesterday. Digital Grid was spun out of Tokyo University in 2013 and is working on a network of kiosks that enables users in Africa to access solar power energy. The university’s investment arm Edge Capital previously participated in a $7.7m series A round alongside Development Bank of Japan, Innovative Venture Fund, J-Power.
